Narrative review compares GLP-1 drugs (semaglutide, tirzepatide) with bariatric surgery for obesity management, covering efficacy, safety, cost, and patient selection.
Drugs catching upGLP-1 drugs (15-21% weight loss) are narrowing the gap with bariatric surgery (25-35%), with next-gen agents approaching surgical results
What the researchers found
Bariatric surgery achieves greater weight loss (25-35%) but GLP-1 drugs (15-21%) are narrowing the gap and offer non-surgical advantages, with combination approaches emerging as optimal.
Why it matters
Patients and clinicians need to choose between increasingly effective drugs and proven surgery. An honest comparison helps make informed decisions.
The numbers in context
Not specified — comprehensive review across treatment modalities.
How the study worked
Narrative review comparing medical (GLP-1 drugs) and surgical obesity management across efficacy, safety, cost, and patient selection criteria.
Who was studied
Adults with obesity considering medical versus surgical treatment options
What this study cannot tell us
Long-term outcomes >10 years available for surgery but not for GLP-1 drugs. Cost comparisons evolve with drug pricing. Surgery has upfront risk while drugs have ongoing cost.
How to read the evidence
Moderate evidence: narrative review synthesizing efficacy data from both treatment approaches.
When this study was published
Published in 2025. Captures the current state of the drugs-vs-surgery debate with latest agents.
The bigger picture
The competition between drugs and surgery is driving innovation in both. Bariatric techniques are becoming less invasive while GLP-1 drugs are becoming more effective. Eventually, the best approach may be personalized — some patients getting drugs, some surgery, and many getting both.
Questions still open
- Will triple agonists like retatrutide match bariatric surgery weight loss?
- Is drug+surgery combination better than either alone?
- Which patients should definitely choose surgery over drugs?
Common questions
Should I choose GLP-1 drugs or bariatric surgery?
Will drugs ever be as effective as surgery?
Read the original research
Medical vs. Surgical Obesity Management: A Narrative Review of Efficacy, Safety, and Long-Term Outcomes.
Cureus, 17(9), e91677
Citation
Akwe, Joyce; Fongeh, Kimela; Jung, Sarah; Hall, Mary Ann Kirkconnell; Patidar, Viniya; Shin, Yoo Mee. (2025). Medical vs. Surgical Obesity Management: A Narrative Review of Efficacy, Safety, and Long-Term Outcomes.. Cureus, 17(9), e91677. https://doi.org/10.7759/cureus.91677